[1]曾胜澜,王娜,张荣臻,等.基于网络药理学探讨茵黄解毒汤治疗HBV相关肝衰竭的活性成分及其作用机制[J].西部中医药,2024,37(02):91-98.[doi:10.12174/j.issn.2096-9600.2024.02.18]
　ZENG Shenglan,WANG Na,ZHANG Rongzhen,et al.Active Components and Its Molecular Mechanism of Yinhuang Jiedu Decoction in the Treatment of HBV - related Liver Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2024,37(02):91-98.[doi:10.12174/j.issn.2096-9600.2024.02.18]
点击复制

基于网络药理学探讨茵黄解毒汤治疗HBV相关肝衰竭的活性成分及其作用机制
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年02期
页码:
91-98
栏目:
二次研究
出版日期:
2024-02-15

文章信息/Info

Title:
Active Components and Its Molecular Mechanism of Yinhuang Jiedu Decoction in the Treatment of HBV - related Liver Failure Based on Network Pharmacology
作者:
曾胜澜1, 王娜1, 张荣臻1, 王挺帅2, 吴聪3, 毛德文1
1.广西中医药大学第一附属医院，广西 南宁 530023
2.湖南中医药大学，湖南 长沙 410000
3.广西中医药大学，广西 南宁 530023
Author(s):
ZENG Shenglan1, WANG Na1, ZHANG Rongzhen1, WANG Tingshuai2, WU Cong3, MAO Dewen1
1.First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning 530023, China
2.Hunan University of Chinese Medicine, Changsha 410000, China
3.Guangxi University of Traditional Chinese Medicine, Nanning 530023, China
关键词:
网络药理学; 茵黄解毒汤; 乙型肝炎病毒; 相关肝衰竭
Keywords:
network pharmacology; decoction; hepatitis B virus; related liver failure
分类号:
R512.6+2
DOI:
10.12174/j.issn.2096-9600.2024.02.18
文献标志码:
A
摘要:
目的采用网络药理学方法研究茵黄解毒汤治疗乙型肝炎病毒（hepatitis B virus，HBV）相关肝衰竭（hepatitis B virus related liver failure，HBV-LF）的活性成分及其分子机制。 方法采用GEO数据库筛选疾病相关差异基因（differentially expressed genes，DEGs），TCMSP数据库筛选中药复方小分子化合物及其作用靶点，Venny 2.1.0进行交集比对，确定交集靶点及其关系。运用Cytoscape构建茵黄解毒汤治疗HBV-LF的调控网络，Bisogenet构建蛋白互作网络（protein-protein interaction network，PPI），CytoNCA进行网络拓扑学分析。利用David数据库进行GO富集分析和KEGG信号通路富集分析。 结果本研究共得到HBV-LF的差异基因2160个，茵黄连解毒汤的药物靶点255个，交集靶点31个，相关小分子化合物66个。小分子化合物包括槲皮素、山柰酚、黄芩素、芦荟大黄素、黄连素等。PPI网络涉及55个关键节点，包括TP53、NTRK1、HSP90AA1、ESR1、CUL3、MCM2、CDK2、HSP90AB1、YWHAZ、NPM1、EGFR等。GO富集分析主要与细胞组分构成或来源、对刺激的反应、免疫过程、正/负调节的生物过程、细胞死亡、细胞增殖等有关。KEGG通路27条，主要涉及PI3K-Akt信号通路、MAPK信号通路、Cell cycle、Hepatitis B、自噬、FoxO信号通路、Ras信号通路、IL-17信号通路、NOD样受体信号通路、HIF-1信号通路、NF-κB信号通路等。 结论茵黄解毒汤拮抗HBV-LF具有“多靶点-多通路-多作用”的特性，其作用机制可能与促进肝细胞增殖分化、降低肝细胞凋亡、调节机体免疫、抑制HBV复制等有关。
Abstract:
ObjectiveTo study the active ingredients of Yinhuang Jiedu decoction in the treatment of hepatitis B virus (HBV)-related liver failure (HBV-LF) and its molecular mechanism using network pharmacology. MethodsGEO was used to screen DEGs, TCMSP database to sift small molecule compound of TCM compounds and the targets of action, Venny 2.1.0 to perform the intersection comparison, identifying intersecting targets and their relationships. Cytoscape was applied to build the regulation network of Yinhuang Jiedu decoction in the treatment of HBV-LF, Bisogenet to construct PPI, CytoNCA to perform network topology analysis. David database to conduct GO enrichment analysis and KEGG signaling pathway enrichment analysis. ResultsThe study gained 2160 DEGs of HBV-LF, 255 targets of Yinhuang Jiedu decoction, 31 intersecting targets and 66 relevant small molecular compounds. Small molecular compounds included quercetin, kaempferol, baicalein, aloe barbadensis, canthaxanthin, etc. PPI network involved 55 key links, covering TP53, NTRK1, HSP90AA1, ESR1, CUL3, MCM2, CDK2, HSP90AB1, YWHAZ, NPM1, EGFR and others. GO enrichment analysis is mainly connected with cellular component composition or the source, the response to the stimuli, immunologic process, biological process of positive/negative regulation, cellular death, cellular proliferation. All 27 KEGG pathways mainly refer to PI3K-Akt signal pathway, MAPK signaling pathway, Cell cycle, Hepatitis B, autophagy, FoxO signaling pathway, Ras signaling pathway, IL-17 signaling pathway, NOD-like receptor signaling pathway, HIF-1 signaling pathway and NF-κB signaling pathway. ConclusionYinhuang Jiedu decoction could treat HBV-LF from multi-target, multi-pathway and multi-effect, and its mechanism might be related to promoting the proliferation and differentiation of hepatocyte, reducing the apoptosis of hepatocyte, regulating body immunity and inhibiting the replication of HBV.

相似文献/References:

[1]杨继红,姚帅君,贺文彬,等.基于数据挖掘和分子对接探讨含党参方剂治疗消渴用药规律及分子机制研究[J].西部中医药,2025,38(08):30.[doi:10.12174/j.issn.2096-9600.2025.08.08]
　YANG Jihong,YAO Shuaijun,HE Wenbin,et al.Medication Rules of Dangshen-containing Prescription in the Treatment of Diabetes Mellitus and Study on Molecular Mechanism: Based on Data Mining and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2025,38(02):30.[doi:10.12174/j.issn.2096-9600.2025.08.08]
[2]赵贺华,杨丽君.基于网络药理学探讨黄芩抗巨细胞病毒感染的作用机制[J].西部中医药,2025,38(08):37.[doi:10.12174/j.issn.2096-9600.2025.08.09]
　ZHAO Hehua,YANG Lijun.Network Pharmacology-based Discussion on the Mechanism of Huangqin in the Treatment of Cytomegalovirus Infection[J].Western Journal of Traditional Chinese Medicine,2025,38(02):37.[doi:10.12174/j.issn.2096-9600.2025.08.09]
[3]顾东彦,王子雯,许孟月,等.基于网络药理学及分子对接探讨参苓白术散治疗特应性皮炎的作用机制[J].西部中医药,2025,38(08):45.[doi:10.12174/j.issn.2096-9600.2025.08.10]
　GU Dongyan,WANG Ziwen,XU Mengyue,et al.Mechanism of Shenling Baizhu Powder in the Treatment of Atopic Dermatitis Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2025,38(02):45.[doi:10.12174/j.issn.2096-9600.2025.08.10]
[4]余林波,周鹍,林谦,等.基于网络药理学和分子对接技术探讨芪参六味方治疗心肌纤维化的作用机制[J].西部中医药,2025,38(08):51.[doi:10.12174/j.issn.2096-9600.2025.08.11]
　YU Linbo,ZHOU Kun,LIN Qian,et al.Based on Network Pharmacology and Molecular Docking: Treatment of Myocardial Fibrosis with Qishen Six-flavor Prescription[J].Western Journal of Traditional Chinese Medicine,2025,38(02):51.[doi:10.12174/j.issn.2096-9600.2025.08.11]
[5]杨竹青,郭敏,徐文倩,等.基于网络药理学和分子对接技术探究绝经后肝纤维化的中药用药规律[J].西部中医药,2025,38(09):46.[doi:10.12174/j.issn.2096-9600.2025.09.10]
　YANG Zhuqing,GUO Min,XU Wenqian,et al.Exploring Medication Rules of Traditional Chinese Medicine in the Treatment of Postmenopausal Liver Fibrosis Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2025,38(02):46.[doi:10.12174/j.issn.2096-9600.2025.09.10]
[6]王莉婷,王成祥,徐广,等.基于网络药理学和分子对接方法探讨红曲茯苓片防治血脂异常的作用机制[J].西部中医药,2025,38(10):72.[doi:10.12174/j.issn.2096-9600.2025.10.13]
　WANG Liting,WANG Chengxiang,XU Guang,et al.Hongqu Fuling Tablets in the Treatment of Dyslipidemia Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2025,38(02):72.[doi:10.12174/j.issn.2096-9600.2025.10.13]
[7]高世龙,杨艳玲,蔡钦钦,等.基于GEO差异表达基因与网络药理学探讨黄芩经铁死亡途径调控2型糖尿病作用机制[J].西部中医药,2025,38(10):81.[doi:10.12174/j.issn.2096-9600.2025.10.14]
　GAO Shilong,YANG Yanling,CAI Qinqin,et al.The Mechanism of Huangqin Regulation in Type 2 Diabetes Mellitus via Ferroptosis Pathway Based on GEO Differentially Expressed Genes and Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2025,38(02):81.[doi:10.12174/j.issn.2096-9600.2025.10.14]
[8]张津铖,程志强.基于网络药理学和分子对接探讨调脾安肠方治疗结直肠癌的作用机制[J].西部中医药,2025,38(10):90.[doi:10.12174/j.issn.2096-9600.2025.10.15]
　ZHANG Jincheng,CHENG Zhiqiang.Mechanism of Spleen-regulating Intestine-calming Formula in the Treatment of Colorectal Cancer Based on Network Pharmacology and Molecular Docking Technology[J].Western Journal of Traditional Chinese Medicine,2025,38(02):90.[doi:10.12174/j.issn.2096-9600.2025.10.15]
[9]陈诗,李素领,刘江凯,等.小柴胡汤治疗原发性肝癌癌性发热的网络药理机制研究[J].西部中医药,2025,38(09):54.[doi:10.12174/j.issn.2096-9600.2025.09.11]
　CHEN Shi,LI Suling,LIU Jiangkai,et al.Network Pharmacology-based Study on Xiaochaihu Decoction in the Treatment of Primary Hepatocarcinoma Fever[J].Western Journal of Traditional Chinese Medicine,2025,38(02):54.[doi:10.12174/j.issn.2096-9600.2025.09.11]
[10]祖悦,陈国忠,王宁,等.基于网络药理学和分子对接技术探究丹参治疗重症急性胰腺炎的作用机制[J].西部中医药,2025,38(09):60.[doi:10.12174/j.issn.2096-9600.2025.09.12]
　ZU Yue,CHEN Guozhong,WANG Ning,et al.Exploring the Mechanism of Danshen in the Treatment of Severe Acute Pancreatitis Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2025,38(02):60.[doi:10.12174/j.issn.2096-9600.2025.09.12]

备注/Memo

备注/Memo:
曾胜澜（1996—），女，硕士学位。研究方向：肝病的中医药防治及研究。国家自然科学基金（81960841，81774236，82060848）；国家中医药管理局“慢性重型肝炎解毒化瘀”重点研究室项目；广西自然科学基金（2020JJA140273）；广西中医药大学校级一般硕士研究生创新项目（YCSY2020011）。
更新日期/Last Update: 2024-02-15